Tadataka Tsuji,Yu-Hua Tseng
Tadataka Tsuji
Adipose tissue has emerged as a dynamic endocrine organ that coordinates systemic energy balance and cardiometabolic health. This Review highlights the dual humoral and neuronal pathways through which adipose tissue regulates systemic metab...
Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes [0.03%]
妊娠期多内分泌代谢性卵巢综合征：病理生理及结局
Helena J Teede,Eszter Vanky,Terhi T Piltonen et al.
Helena J Teede et al.
Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome, is a chronic condition driven by genetic, epigenetic and lifestyle factors. The resulting endocrine changes, including hyperinsulinaemia and hyper...
Andreas L Birkenfeld,Mathias Heikenwälder
Andreas L Birkenfeld
Elucidating the structure of TRH: a defining moment for modern neuroendocrinology [0.03%]
TRH结构的阐明：现代神经内分泌学的一个关键时刻
Mirela-Diana Ilie
Mirela-Diana Ilie
Claire Greenhill
Claire Greenhill
Senegal Carty
Senegal Carty
Aldosterone synthase inhibitors for the treatment of cardiovascular disease [0.03%]
醛固酮合酶抑制剂在心血管疾病治疗中的应用
Gian Paolo Rossi,Federico Bernardo Rossi,Andrea Cignarella et al.
Gian Paolo Rossi et al.
Aldosterone is essential for maintaining blood pressure during hypovolaemia and/or dehydration through genomic actions mediated by the mineralocorticoid receptor and rapid signalling pathways involving the G-protein-coupled oestrogen recept...
Causes and consequences of discontinuation of GLP1RAs or tirzepatide [0.03%]
GLP-1受体激动剂或 tirzepatide 治疗的停止原因及其后果
Antonio Ceriello,Francesco Prattichizzo,Abdul Raouf Mastan Sheik Abdullah et al.
Antonio Ceriello et al.
Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists and tirzepatide, a dual GLP1R and glucose-dependent insulinotropic polypeptide receptor agonist, have become fundamental in managing type 2 diabetes mellitus (T2DM) and obesity due to...